About Erasca, Inc. 
Erasca, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 36 Schemes (14.58%)
Foreign Institutions
Held by 71 Foreign Institutions (6.97%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-29 Million
Pharmaceuticals & Biotechnology
USD 4,199 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.81
-33.97%
12.07






